Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
name
CureVac BV
CVAC.US
As of December 18, 2025, CureVac N.V. was acquired by BioNTech SE. CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy.
1.820 T
CVAC.USMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
D
BiotechnologyIndustry
Industry Ranking0/386
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE0.00%D
    • Profit Margin182.11%A
    • Gross Margin99.31%A
  • Growth ScoreD
    • Revenue YoY-86.69%E
    • Net Profit YoY21.61%B
    • Total Assets YoY0.00%D
    • Net Assets YoY0.00%D
  • Cash ScoreE
    • Cash Flow Margin-93.26%E
    • OCF YoY-86.69%E
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreB
    • Gearing Ratio23.48%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --